000 01225 a2200313 4500
005 20250516204211.0
264 0 _c20150413
008 201504s 0 0 eng d
022 _a1592-8721
024 7 _a10.3324/haematol.2013.099663
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTong, Wing H
245 0 0 _aDesensitization protocol should not be used in acute lymphoblastic leukemia patients with silent inactivation of PEGasparaginase.
_h[electronic resource]
260 _bHaematologica
_cJul 2014
300 _ae102-4 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't
650 0 4 _aAntibodies
_ximmunology
650 0 4 _aAsparaginase
_xadministration & dosage
650 0 4 _aDesensitization, Immunologic
650 0 4 _aHumans
650 0 4 _aHypersensitivity
_xcomplications
650 0 4 _aPolyethylene Glycols
_xadministration & dosage
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xcomplications
700 1 _aPieters, Rob
700 1 _aTissing, Wim J E
700 1 _avan der Sluis, Inge M
773 0 _tHaematologica
_gvol. 99
_gno. 7
_gp. e102-4
856 4 0 _uhttps://doi.org/10.3324/haematol.2013.099663
_zAvailable from publisher's website
999 _c23689579
_d23689579